FDA Inspection 1175141 — Tarmac Products, Inc.

Tarmac Products, Inc. — FEI 1025483

The FDA completed an inspection of Tarmac Products, Inc. on Jul 22, 2022 in Miami Gardens, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami Gardens, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.